Estrov Z - Search Results

1

Detection of minimal residual disease in all: biology, methods, and applications.

Roberts WM, Estrov Z, Kitchingman GR, Zipf TF. Roberts WM, et al. Among authors: estrov z. Cancer Treat Res. 1996;84:149-66. doi: 10.1007/978-1-4613-1261-1_8. Cancer Treat Res. 1996. PMID: 8724630 Review.

2

Differentiation in B-precursor acute lymphoblastic leukemia cell populations with CD34-positive subpopulations.

Re GG, Estrov Z, Antoun GR, Felix EA, Pinkel DP, Zipf TF. Re GG, et al. Among authors: estrov z. Blood. 1991 Aug 1;78(3):575-80. Blood. 1991. PMID: 1713508 Free article.

3

Growth factors controlling interleukin-4 action on hematopoietic progenitors.

Ferrajoli A, Zipf TF, Talpaz M, Felix EA, Estrov Z. Ferrajoli A, et al. Among authors: estrov z. Ann Hematol. 1993 Dec;67(6):277-84. doi: 10.1007/BF01696347. Ann Hematol. 1993. PMID: 7506581

4

Interleukin 4 alters human bone marrow stroma and modulates its interaction with hematopoietic progenitors.

Ferrajoli A, Talpaz M, Ordonez NG, Stanley ER, Hirsch-Ginsberg C, Zipf TF, Wetzler M, Kurzrock R, Estrov Z. Ferrajoli A, et al. Among authors: estrov z. Stem Cells. 1994 Nov;12(6):638-49. doi: 10.1002/stem.5530120611. Stem Cells. 1994. PMID: 7533582

5

Detection of minimal residual disease in acute lymphoblastic leukemia.

Roberts WM, Estrov Z, Zipf TF. Roberts WM, et al. Among authors: estrov z. Blood. 1995 Aug 1;86(3):1237-9. Blood. 1995. PMID: 7620179 Free article. No abstract available.

6

Accurate quantitation of residual B-precursor acute lymphoblastic leukemia by limiting dilution and a PCR-based detection system: a description of the method and the principles involved.

Ouspenskaia MV, Johnston DA, Roberts WM, Estrov Z, Zipf TF. Ouspenskaia MV, et al. Among authors: estrov z. Leukemia. 1995 Feb;9(2):321-8. Leukemia. 1995. PMID: 7869771

7

Minimal residual leukaemia.

Estrov Z, Ouspenskaia MV, Zipf TF, Tubergen DG, Roberts WM. Estrov Z, et al. Lancet. 1994 Apr 2;343(8901):858-9. doi: 10.1016/s0140-6736(94)92062-1. Lancet. 1994. PMID: 7908106 No abstract available.

8

Leukemia inhibitory factor in long-term adherent layer cultures: increased levels of bioactive protein in leukemia and modulation by IL-4, IL-1 beta, and TNF-alpha.

Wetzler M, Estrov Z, Talpaz M, Kim KJ, Alphonso M, Srinivasan R, Kurzrock R. Wetzler M, et al. Among authors: estrov z. Cancer Res. 1994 Apr 1;54(7):1837-42. Cancer Res. 1994. PMID: 8137298

9

Inhibition of acute myelogenous leukemia progenitor proliferation by macrophage inflammatory protein 1-alpha.

Ferrajoli A, Talpaz M, Zipf TF, Hirsch-Ginsberg C, Estey E, Wolpe SD, Estrov Z. Ferrajoli A, et al. Among authors: estrov z. Leukemia. 1994 May;8(5):798-805. Leukemia. 1994. PMID: 8182937

10

Immature and differentiated neoplastic populations in acute lymphoid leukemia of childhood: biological and clinical implications.

Estrov Z, Re GG, Zipf TF. Estrov Z, et al. Leuk Lymphoma. 1993 Sep;11(1-2):1-7. doi: 10.3109/10428199309054724. Leuk Lymphoma. 1993. PMID: 8220141 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

506 results

Search Page

Filters